A case-control study identifying chromosomal polymorphic variations as forms of epigenetic alterations associated with the infertility phenotype
Objective
To study the association of chromosomal polymorphic variations with infertility and subfertility.
Design
A comparative case-controlled association study using cytogenetic techniques to compare the frequency of chromosomal variations in infertile individuals versus fertile controls.
Setting
Department of Infertility Management and Assisted Reproduction, Jaslok Hospital and Research Centre, Mumbai, India.
Patient(s)
760 infertile individuals and 555 fertile controls.
Intervention(s)
ICSI, IUI, karyotyping, inverted 4′,6-diamidino-2-phenylindole (DAPI), CBG banding.
Main Outcome Measure(s)
Frequency of chromosomal polymorphic variations in infertile individuals undergoing infertility treatment versus fertile individuals.
Result(s)
A highly statistically significant increase in the frequency of total chromosomal variants in infertile women (28.31% vs. 15.16%) and infertile men (58.68% vs. 32.55%) was observed. The frequency of 9qh+ was statistically significantly increased in women with primary infertility (16.22% vs. 6.41%) and in men with severe male factor infertility (14.69% vs. 4.25%). A highly statistically significant increase in the frequency of Yqh+ was observed in men whose wives had a bad obstetric history (30.20% vs. 12.74%).
Conclusion(s)
The statistically significantly higher incidence of heterochromatic variations found in infertile individuals stresses on the need to evaluate their role in infertility and subfertility. Potential epigenetic, genetic, and chromosomal modifications could be associated with certain complex disorders such as infertility and bad obstetric history.
Key Words: Chromosomal variations, 9qh+, Yqh+, infertility, bad obstetric history, recurrent spontaneous abortions, male factor infertility, epigenetics
To access this article, please choose from the options below
S.M. has nothing to disclose. A.S.A. has nothing to disclose. P.F.M. has nothing to disclose. D.K. has nothing to disclose. S.A.U. has nothing to disclose. F.R.P. has nothing to disclose.
Supported and funded by research project grants RP 398 and 317 of Jaslok Hospital and Research Centre Mumbai, India.
PII: S0015-0282(08)01186-2
doi:10.1016/j.fertnstert.2008.05.071
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

